Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response (Q81515023)
Jump to navigation
Jump to search
scientific article published on 29 October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response |
scientific article published on 29 October 2007 |
Statements
Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response (English)
Braun J
Baraliakos X
Listing J
Fritz C
Alten R
Burmester G
Krause A
Schewe S
Schneider M
Sörensen H
Zeidler H
29 October 2007